Trends of Translational Medicine for Oncology
A special issue of International Journal of Translational Medicine (ISSN 2673-8937).
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 18602
Special Issue Editor
Interests: in silico pharmacology; PBPK; drug metabolism; drug combination; drug delivery; peptides; ADME; DMPK; pharmacokinetic
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Translational research is crucial in informing clinical practice and trials. Bringing researchers and clinicians together and combining clinical information with basic research findings is the way to move the field forward, find the best solutions, and beat cancer. This Special Issue is actively conducting translational medicine research to further the understanding of cancer biology and to identify which patient populations may be more likely to benefit from treatments. Our goal is to develop new diagnostic procedures and more targeted treatment approaches by investigating the molecular and functional properties of different cancers. In addition, this Special Issue will evaluate potential diagnostic tools to help identify in patients biomarkers that require less invasive methods.
In the area of preclinical translation, there are numerous application-oriented lab projects focused on the pathogenesis of different cancers in order to identify new diagnostic options and points of attack for targeted treatments. In the area of clinical translation, the focus includes the development and systematic use of tools for comprehensive molecular, cellular, and functional characterization of individual tumors.
This Special Issue will include (but is not limited to) papers on:
- biomarkers and pharmacodiagnostics;
- imaging and technologies;
- radiation oncology;
- bioinformatics and integrated sciences;
- clinical pharmacology and pharmacometrics.
Prof. Dr. Nuno Vale
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Translational Medicine is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacogenomic
- individualized therapy
- PBPK studies
- tumor microenvironment
- immuno-oncology
- translational oncology
- drug repurposing in oncology
- process modeling
- clinical trials
- molecular and functional properties of cancers